[1] |
LUO Gan, YI Chao, YIMAMUMAIMAITIJIANGo Abula, XU Lin, YIN Jiwei, DING Wei.
Expression of Notch signaling pathway in pancreatic cancer and its role
[J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 1-7.
|
[2] |
PEI Lei, CAI Ceng, MAO Rui, Ailijang.Tu-er-xun, ZHAO Huarong, ZHANG Hua, BAO Yongxing.
Prognostic analysis of 313 aged pancreatic cancer patients in hospital treatment between Uygur and Han nationality in Xinjiang area
[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(1): 1-6.
|
[3] |
LIU Xian, REN Gang, LI Liqin, ZHU Fuhai, XIA Tingyi.
Analysis of relative factors on gastrointestinal toxicity with TOMO hypofractioned radiotherapy for pancreatic adenocarcinoma
[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(6): 481-486.
|
[4] |
ZHAN Chao,JIN Yu,ZHANG Yubao.
Comparison between CA19-9,CEA and specific N-Glycans in early middle stage pancreatic carcinoma serum
[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(1): 7-11.
|
[5] |
XU Jingjing,YANG Ming,ZHAO Juan,ZHOU Yanhua,ZHANG Yanqiao.
Clinical analysis of prognostic factors in the postoperative pancreatic cancer
[J]. PRACTICAL ONCOLOGY JOURNAL, 2012, 26(6): 543-547.
|
[6] |
.
[J]. PRACTICAL ONCOLOGY JOURNAL, 2011, 25(5): 453-456.
|
[7] |
.
[J]. PRACTICAL ONCOLOGY JOURNAL, 2010, 24(5): 490-493.
|
[8] |
GU Haitao, SHI Xin, LIN Shibo, ZHANG Yi, YANG Jun, QIAN Chengjia.
The expression and significance of PTEN and PIK3CA in pemetrexed-resistant human pancreatic cancer cell line Patu8988
[J]. PRACTICAL ONCOLOGY JOURNAL, 2010, 24(2): 112-116.
|
[9] |
LUAN Jinwei, YOU Qingshan.
Effects of 3D-CRT combined with chemotherapy and chemotherapy alone in advanced pancneatic cancer
[J]. PRACTICAL ONCOLOGY JOURNAL, 2009, 23(4): 328-331.
|
[10] |
.
[J]. PRACTICAL ONCOLOGY JOURNAL, 2009, 23(4): 350-352.
|
[11] |
HUANG Xiaohui, QIU Qiande.
MSCT diagnosis of pancreatic adenocarcinoma
[J]. PRACTICAL ONCOLOGY JOURNAL, 2009, 23(3): 222-224.
|